Phase 3 Study of DW-330SR2 and Pelubiprofen in Chronic Back Pain Patients

Clinical trial NCT02375633 · COMPLETED

Trial details

NCT number: NCT02375633
Sponsor: Daewon Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Back Pain

Start date: 2014-04-01
Primary completion: 2014-11-01
Enrollment: 166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.